Meaning
High-risk medical instruments designed to be implanted into the human body or used for life-support functions require the highest level of regulatory evaluation and clinical testing. Foreign and domestic Class III medical devices must be approved directly by the National Medical Products Administration in Beijing. This category covers products such as pacemakers, artificial joints and vascular stents.
It holds the most stringent operational boundary, meaning that no sales are permitted until a formal registration certificate is issued.
Clinical Evaluation
Rigorous clinical trials conducted within certified domestic hospitals are typically mandatory to prove the safety of high-risk medical hardware. For Class III medical devices, the manufacturer must coordinate with multiple clinical trial sites to gather sufficient patient data. This process is audited by national inspectors who verify the data integrity of all clinical records.
Manufacturing Supervision
State inspectors enforce strict adherence to manufacturing practices through unannounced audits of production facilities. Production of Class III medical devices must occur in sterile environments that meet strict particle limits. These facilities are subject to regular inspections by the national regulator to ensure that quality management systems are functioning continuously.
Agent Responsibility
Appointing a domestic representative is required for foreign manufacturers to manage the post-market surveillance of high-risk hardware. The agent for Class III medical devices is legally responsible for reporting adverse events and coordinating product recalls. This structural link ensures that the regulator has a direct legal entity to penalize if the product causes harm.
